Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing trilostane (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing hexestrol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
indsættelse af Norplant |
Direct substance |
False |
Hormone |
Inferred relationship |
Some |
2 |
Implantation of hormone implant |
Direct substance |
False |
Hormone |
Inferred relationship |
Some |
1 |
syntetisk hormonpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Hormone implant operation NOS |
Direct substance |
False |
Hormone |
Inferred relationship |
Some |
1 |
Accidental thiouracil poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Intentional thiouracil poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med thiouracil, uvist med hvilken hensigt |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Carbimazole poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Accidental carbimazole poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Intentional carbimazole poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med carbimazol, uvist med hvilken hensigt |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
accidentel forgiftning med desoxycorticosteronderivat |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
tilsigtet forgiftning med desoxycorticosteronderivat |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med desoxykortikosteronderivat, uvist med hvilken hensigt |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Accidental fluorinated corticosteroid poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Intentional fluorinated corticosteroid poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med fluorineret kortikosteroid, uvist med hvilken hensigt |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Accidental insulin poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Intentional insulin poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med insulin, uvist med hvilken hensigt |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med oralt hypoglykæmikum |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Accidental poisoning by glibenclamide |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Intentional poisoning by glibenclamide |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med glibenclamid, uvist med hvilken hensigt |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Accidental poisoning by metformin |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Intentional poisoning caused by metformin (disorder) |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med metformin, uvist med hvilken hensigt |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Accidental phenformin poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Intentional phenformin poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med phenformin, uvist med hvilken hensigt |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Sex hormone poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Intentional liothyronine poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med liothyronin, uvist med hvilken hensigt |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Intentional thyroxin poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
accidentel forgiftning med levotyroxinnatrium |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
tilsigtet forgiftning med levothyroxinnatrium |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med levothyroxinnatrium, uvist med hvilken hensigt |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Forgiftning med hypothalamus-/hypofysehormon |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Accidental vasopressin poisoning (disorder) |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Intentional vasopressin poisoning |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med vasopressin, uvist med hvilken hensigt |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Implantation of subcutaneous contraceptive in arm |
Direct substance |
False |
Hormone |
Inferred relationship |
Some |
2 |
Product containing clomifene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Poisoning by liothyronine |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Endocrine drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Drugs for hypoglycemia |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Diabetic neuropathy treatment [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Thyroxine sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Thyroxine sodium 25micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Thyroxine sodium 50micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Thyroxine sodium 100micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing carbimazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Carbimazole 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Carbimazole 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Propylthiouracil 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Corticosteroid replacement therapy |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Steroid disease suppression [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Corticosteroid disadvantages [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Clinical corticosteroid therapy |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Estrogens |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Estropipate 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing quinestradol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Combined oestogen+progestogen preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Menstrual symptons - combined preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Estradiol valerate 2 mg and norethisterone 700 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Menstrual disorder comb.preps |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Male sex hormones and antagonists |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Cyproterone acetate [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Finasteride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Hypothalamic+anterior pituitary hormones |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Clomifene citrate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing cyclofenil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Human menopausal gonadotrophins 75iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Human menopausal gonadotrophins 150iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Antidiuretic hormone antagon. [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing gonadorelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Metyrapone 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Endometriosis drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Gestrinone 2.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing precisely trilostane 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing precisely trilostane 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Other drugs used in diabetes |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Other endocrine drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Raloxifene hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Raloxifene hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
luteiniserende hormon-frigørende hormon-antagonistprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing cetrorelix (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
cetrorelix 0,25 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
cetrorelix 3 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing ganirelix (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
ganirelix 500 µg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Mifepristone 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Topical hormones for vaginal+vulval conditions |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Combined oral contraceptive - ethinylestradiol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Desogestrel 150 microgram and ethinylestradiol 20 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|